NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
16 hedge funds and large institutions have $673K invested in InVivo Therapeutics Holdings Corp in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$16.3K | |
| 2 | +$4.48K | |
| 3 | +$3K | |
| 4 |
Citigroup
New York
|
+$1K |
| 5 |
State Street
Boston,
Massachusetts
|
+$743 |
Top Sellers
| 1 | -$98.3K | |
| 2 | -$58K | |
| 3 | -$21K | |
| 4 |
HF
HRT Financial
New York
|
-$11K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$8K |